|
Online Database of Chemicals from Around the World | Search | Submit | Advertise | |
Home >> Chemical Listing >> TLN-232>> Market Analysis Reports |
Market Analysis Reports of TLN-232 |
|
Thallion Pharmaceuticals, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis Thallion Pharmaceuticals, Inc. focuses on anticancer therapies from soildwelling microorganisms using its discovery platform called the DECIPHER technology. The company focuses on moving its anticancer compound, ECO-4601, through a Phase I clinical trial ... |